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Available online 29 October 2015AbstractObjectives: In hip fracture patients, studies about relevance between localized proximal femoral bone mineral density (BMD) and the fracture
sites of hip are very rare. We compared T-scores of each femoral neck and trochanteric portion in a femoral neck fracture patients group (NFP)
and in an intertrochanteric fracture patients group (IFP). Our hypothesis is that the T-score of neck portion is lower than the T-score of
trochanteric portion in NFP and vice versa. We evaluated how the FRAX® probability is meaningful in hip fracture patients.
Methods: 180 hip fracture patients were included and evaluated by BMD. We compared the average of T-scores between neck and trochanteric
portion in each group. Differences between the regional T-score of neck and trochanteric portion were calculated in each patient and compared
between two groups. We calculated the FRAX® probability in each patient and compared between two groups.
Results: For the two groups, the average of the T-scores in neck portion was lower than the T-scores in trochanteric portion. In NFP, the average
of difference between the regional BMD of neck portion and trochanteric portion was greater than that of IFP. FRAX® probability of hip fracture
in NFP was higher than that in IFP. 77.3% of NFP and 80.8% of IFP were classified as high risk group for hip fracture.
Conclusion: The localized femoral BMD data supports that localized femoral T-scores are relevant to the fracture sites of the hip. The high risk
group designated by FRAX® is a sensitive tool to evaluate hip fractures in osteoporotic patients.
© 2015 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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It is well-known that osteoporotic fracture patients,
including hip fractures, spine fractures, and distal radius
fractures, have low T-scores in bone mineral density (BMD)
evaluations [1]. Despite the strong associations between BMD
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).risk factors including epidemiologic estimates, and the past
history of patients can attribute to the risk of osteoporotic
fractures [2]. Recently, WHO (World Health Organization)
introduced FRAX® (Fracture Risk Assessment Tool) algo-
rithms that allows an estimation of individual 10-year major
osteoporotic and hip fracture probabilities. These algorithms
integrate the influence of several well-validated clinical risk
factors for fractures with BMD. It is very useful for the pre-
diction of osteoporotic fractures, such as hip fractures, spine
fractures, and distal forearm fractures [3,4]. The National
osteoporosis foundation (NOF) of the United States and
Osteoporosis Canada established the FRAX® designation of
the high risk group for osteoporotic fractures (Defined as 10-
years major osteoporotic fracture probabilities  20% or 10-Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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of the high risk group for osteoporotic fractures is used for
criteria as pharmacologic intervention for osteoporotic
patients.
Femoral neck fracture and intertrochanteric fracture are
well-known as the major anatomical types of hip fractures. But
two types of hip fracture have some different clinical courses.
Fox et al. [7] reported that most intertrochanteric fractures
(91%) were repaired by internal fixation whereas femoral neck
fracture were repaired either by internal fixation (30%) or
arthroplasty (66%). They also reported that intertrochanteric
fracture patients had longer hospital stay and higher mortality
rates during the hospitalization and at 6 month after fracture.
There have been many studies focusing on prediction and
prevention of osteoporotic hip fractures by BMD and FRAX®
tool. However, despite BMD with DEXA (Dual-Energy X-ray
Absorptiometry) machine can diffenciate the localized prox-
imal femoral T-score, neck portion and trochanteric portion,
studies about relevance between localized proximal femoral
BMD and the fracture sites of the hip are very rare. Also, there
is not enough data for a comparison of 10-year probabilities of
osteoporotic fractures by FRAX® between patients who
experienced femoral neck fractures and intertrochanteric
fractures.
In this study, we classified hip fracture patients as those of a
femoral neck fracture patients group (NFP) and an inter-
trochanteric fracture patients group (IFP). We measured the T-
scores of the femoral neck, trochanteric, and total femur in
each group. By this, we expected to identify the role of
localized femoral BMD in the prediction of osteoporotic hip
fractures.
Using the FRAX® tool, we calculated 10-year probabilities
of major osteoporotic fractures (MOF) and 10-year osteopo-
rotic hip fractures for each patient. We wanted to investigate
the difference in probabilities between the two groups. We
also investigated how many patients were included in the two
groups by the FRAX® designation of the high risk group for
osteoporotic fractures. By this, we wanted to identify the
sensitivity of the FRAX® designation of the high risk group.
2. Materials and methods
From April, 2003 to September, 2012, 180 hip fracture
patients were included in our study. The study design was a
restrospective study. The inclusion criteria were: 1) unilateral
hip fracture patients 2) patients who were evaluated by BMD
using DEXAwithin two weeks after surgery 3) age of patients
55 years old. The exclusion criteria were: 1) Hip fracture
patients who were not evaluated by BMD 2) Pathologic frac-
ture patients with primary bone tumor, tumor metastasis, and
underling osteogenesis imperfecta. 3) High energy trauma
patients injured by more than 5 m fall down or traffic accident.
98 patients were femoral neck fracture patients and 82 patients
were intertrochanteric fracture patients. Four patients over 90
years old, one in the NFP, the others in the IFP, were excluded
for the FRAX® analysis because of the age range of the
FRAX®, 40e90 years. All of the patients were Korean. In theNFP, 18 patients were men and 80 patients were women. In the
IFP, 25 patients were men and 57 patients were women. All
patients were evaluated by BMD using DEXA (from 2003 to
2010: QDR-4500a by Hologic, from 2010 to 2012: Prodigy
Advance by GE) within two weeks after surgery. We measured
localized BMD in each patient by categorizing the femoral
neck, intertrochanteric area and total femur area. We
compared the average of the T-scores between the neck
portion and the trochanteric portion in each group. Differences
between the regional BMD (T-score) of the neck portion and
the trochanteric portion were calculated in each group. The
average of the differences was compared between the two
groups.
Calculating the FRAX® probability was done by an algo-
rithm by the WHO from the website (http://www.shef.ac.uk/
FRAX, Calculation Tool for South Korean) and we checked
statistical differences in each group. We also checked how
many patients in each group were included in the high risk
group by the FRAX® designation defined as 10-year major
osteoporotic fracture probability 20% or 10-year hip fracture
probability 3%. By this, we wanted to check the sensitivity
of the high risk group for osteoporotic fractures by FRAX®
designation in the hip fracture patients. One patient of the NFP
and three patients of the IFP were excluded for FRAX®
probability because they were over 90 years old (FRAX® has a
limited age range from 40 years to 90 years old).
The t-test, paired t-test, chi-square test, and the logistic
regression analysis were used for the statistical methods. The
t-test was used for the comparison between two group about
the localized T-scores and the FRAX probability. Chi-square
test and the t-test were used for comparing demographics of
the patients in each group. Paired t-test was used for the
comparison between localized T-scores in the same patients.
Logistic regression test was used for the adjustment of the
BMI which was different between two group. We used SPSS
19.0 (SPSS Inc., Chicago, Illinois, USA) for statistical anal-
ysis. Our study was approved by IRB (Approval number: IUH-
IRB 13-0638).
3. Results
At first, We investigated age, sex, BMI and several his-
tories, previous history of fractures, family history of fractures,
steroid use, smoking, rheumatoid arthritis, alcohol consump-
tion and history for secondary osteoporosis in each patient
(Table 1). Only BMI was statistically different between two
groups. These data were used for calculating the FRAX®
probability in each patient. About osteoporosis medication, 7
patients were taking bisphosphonate in NFP and 5 patients
were taking bisphosphonate in IFP. 1 patient in IFP was taking
SERM (Selective Estrogen Receptor Modulator).
In the NFP, the average of the T-scores in the neck portion
was lower (3.23 ± 0.91, range: 1.4 ~ 5.1) than the T-
scores in the trochanteric portion (2.55 ± 1.17, range:
0.6 ~ 5.5). In the IFP, the average of the T-scores in the neck
portion was also lower (2.93 ± 0.93, range: 0.6 ~ 4.6)
than the T-scores in the trochanteric portion (2.56 ± 0.93,
Table 1
Demographics of patients in each group.
Neck fracture
patients group
Intertrochanteric
fracture patients group
p
Age (y) 72.9 (55e98) 74.0 (55e96) 0.39
Sex M: 18, F: 80 M: 25, F: 57 0.058
Weight (kg) 53.8 (32e78) 56.3 (38e80) 0.095
BMI (kg/cm2) 21.8 (13.3e30.3) 22.8 (15.4e33.3) 0.049
Previous fracture
history
12/98 (12.2%) 15/82 (18.2%) 0.18
RA history 4/98 (4.1%) 0/82 (0%) 0.064
Smoking 11/98 (11.2%) 9/82 (11.0%) 0.958
Alcohol 9/98 (9.2%) 8/82 (9.8%) 0.896
Steroid use 3/98 (3.1%) 0/82 (0%) 0.110
The t-test was done for Age, weight, BMI.
The range of Age, BMI, Weight are given in the bracket.
The Chi-square test was done for sex, previous fracture history, RA history,
smoking, alcohol, steroid use.
BMI: body mass index.
Fig. 2. Difference between T-scores of neck portion and trochanteric portion. *
The bar means the average of the difference between the regional BMD (T-
score) of the neck portion and the trochanteric portion. (For the neck fracture
patients group, localized neck BMD: 3.23, localized trochanteric BMD:
2.55, difference: 0.68). *p < 0.001 for the difference between two group
about the differences between T-scores of neck portion and trochanteric
portion (t-test was used). BMD: bone mineral density.
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neck and the trochanteric portions in the two groups were
statistically significant (p < 0.001) (Fig. 1).
In the NFP, the average of the difference between the
regional BMD (T-score) of the neck portion and the trochan-
teric portion (neck: 3.23, trochanteric: 2.55, difference:
0.68) was greater than the average of the difference between
the regional BMD (T-score) of the neck portion and the
trochanteric portion in the IFP (neck: 2.93, trochanteric:
2.56, difference: 0.37) with statistical significance
(p < 0.001) (Fig. 2).
In the NFP, the average of the T-scores in the neck portion
(3.23 ± 0.91, 1.4 ~ 5.1) was lower than the average of
the T-scores in the neck portion in the IFP with statistical
significance (2.93 ± 0.93, range: 0.6 ~ 4.6, p ¼ 0.029).
In the IFP, the average of the trochanteric T-scoreFig. 1. Localized BMD T-score in femoral neck fracture patients and inter-
trochanteric fracture patients. * Blue bar means the regional T-scores of the
Neck fracture patients group and Red bar means the regional T-scores of the
intertrochanter fracture patients group. *p ¼ 0.029 for the difference between
two group about the T-scores in neck portion (t-test was used). *p ¼ 0.95 for
the difference between two group about the T-scores in trochanteric portion (t-
test was used). *p ¼ 0.28 for the difference between two group about the T-
scores in total femur (t-test was used). *p < 0.001 for the differences between
the T-scores of the neck portion and the trochanteric portion in neck fracture
group (paired t-test was used). *p < 0.001 for the differences between the T-
scores of the neck portion and the trochanteric portion in intertrochanteric
fracture group (paired t-test was used). BMD: bone mineral density.(2.56 ± 0.93, range: 0.2 ~ 4.3) was lower than the
average of the trochanteric T-score of the NFP without sta-
tistical significance (2.55 ± 1.17, range: 0.6 ~ 5.5,
p ¼ 0.95). The average of the total femoral T-scores in the
NFP (2.92 ± 1.10, range: 0.5 ~ 5.3) was lower than the
average of the total femoral T-scores in the IFP without sta-
tistical significance (2.75 ± 0.93, range: 0.5 ~ 5.4,
p ¼ 0.28) (Fig. 1).
The FRAX® probability of the major osteoporotic fractures
in the NFP (14.4%) was higher than in the IFP (11.1%,
p ¼ 0.009). The FRAX® probability of the osteoporotic hip
fracture in the NFP (8.6%) was higher than the IFP group
(5.9%, p ¼ 0.008) (Fig. 3).
19.5% of the NFP (19/97) and 10.1% of the IFP (8/79) were
classified as high risk group by the FRAX® designation for
MOF. 77.3% of the NFP (75/97) and 80.8% of the IFP (64/79),
totally 79% of the hip fracture patients (139/176), were clas-
sified as high risk group via FRAX® for osteoporotic hip
fractures (Table 2).Fig. 3. 10-years Fracture probability calculated by the FRAX® tool in femoral
neck fracture patients and intertrochanteric fracture patients. *p ¼ 0.009 for
the difference between two group about probability of major osteoporotic
fracture (t-test was used). *p ¼ 0.008 for the difference between two group
about probability of hip fracture (t-test was used).
Table 2
Percentage of the high risk group for osteoporotic fractures designated by the FRAX® tool in femoral neck fracture patients and intertrochanteric fracture patients.
High risk group for osteoporotic fracture Neck fracture patients group Intertrochanteric fracture patients group Total patients
Major osteoporotic fractures (FRAX® probability > 20%) 19/97 (19.50%) 8/79 (10.1%) 27/176 (15.3%)
Hip osteoporotic fracture (FRAX® probability of hip >3%) 75/97 (77.3%) 64/79 (80.8%) 139/176 (79.0%)
p ¼ 0.15 about the percentage of the high risk group for the major osteoporotic fracture between two groups (chi-square test).
p ¼ 0.47 about the percentage of the high risk group for the hip osteoporotic fracture between two groups (chi-square test).
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(p ¼ 0.049, Table 1), we performed logistic regression analysis
for the adjustment of BMI. Even after the adjustment of BMI,
the differences between two group about ‘the differences be-
tween T-scores of neck portion and trochanteric portion’,
‘FRAX probability of major osteoporotic fracture’, and
‘FRAX probability of hip fracture’ were still statistically
significant (Table 3).
4. Discussion
In developing countries, with the increasing number of
elderly people, the incidence of osteoporosis and osteoporotic
fracture is increasing. Several osteoporotic fractures such as
hip fractures and vertebral fractures have a very high
morbidity and mortality. These fractures not only decrease the
patient's quality of life, but increase the burden of health care
costs on societies [8,9]. Of special note, proximal femur
fractures are well-known as major health problems in old age
with increasing morbidity, mortality, and health care costs
[10]. For the prevention of osteoporotic fractures, many
studies tried to create criteria to identify those who would be
candidates for pharmacological intervention in osteoporotic
patients.
Osteoporotic hip fractures can be classified as femoral neck
fractures and femoral intertrochanteric fractures. There are
several reports that analyzed BMD and skeletal factors of hip
fractures. Some studies tried to find differences of skeletal
factors in femoral neck fractures and femoral intertrochanteric
fractures. Gnudi et al. [11] measured femoral geometric fac-
tors such as hip axis length (HAL), neck-shaft angle by DXA
study, and found that patients with femoral neck fractures
showed longer HAL and larger NSA than patients with
trochanteric fractures. Mautalen et al. [12] reported trochan-
teric fractures are more related to severe osteoporosis mainly
in the trabecular compartment, whereas femoral neck fracturesTable 3
Logistic regression analysis for the adjustment of BMI about localized BMD T-sc
trochanteric fracture patients.a
Crude OR 95% CI
T-score of Neck portion 0.697 0.502e0.968
T-score of Trochanteric portion 1.008 0.765e1.329
T-score of total portion 0.853 0.638e1.140
Differencesb 2.307 1.368e3.889
FRAX probability (Major) 1.054 1.012e1.0980
FRAX probability (Hip) 1.075 1.016e1.137
BMD: bone mineral density, BMI: body mass index.
a In the table, odd ratio means the ratio between neck fracture patient group to
b Difference between T-scores neck portion and trochanteric portion in the sameare more related to pelvic bone and hip geometry. However,
regional differences in bone mineral density at the proximal
femur between femoral neck fracture patients and inter-
trochanteric fracture patients are not well-known. In 2002,
Gundi et al. [11] suggested that women with trochanteric
fractures had lower BMD in the femoral neck and trochanteric
regions than women with femoral neck fractures on DXA. In
2011, Yuki Maeda et al. [13] investigated differences in the
BMD of the femur between femoral neck fractures and
intertrochanteric fractures. They reported that there's no sig-
nificant difference in bone mineral density between the two
groups in the three regions e the femoral head, femoral neck,
and trochanteric regions.
In this study, T-scores in the neck portion were lower than
T-scores in the trochanteric portion in each group with sta-
tistical significance. However, in the NFP, the average of the
differences between the T-scores in the neck portion and T-
scores in the trochanteric portion were greater than the average
of the differences in the IFP group. We used the difference
between the T-scores in the neck portion and the trochanteric
portion in each patient because regional T-scores of each
group can be influenced by the base BMD of patients in each
group. These data support the hypothesis that localized BMD
can be a predictive factor for osteoporotic fractures. Further
study for the more reason of this result may be needed.
The average T-score of the femoral neck portion in the NFP
was lower than in the IFP with statistical significance. The T-
scores of the trochanteric portion in the IFP was lower than
those in the NFP, even if it was not statistically significant.
These data can be influenced by the difference of the base T-
score in each group (Total femoral T-scores, NFP: 2.92 IFP:
2.75). However, the difference of the total femoral T-scores
between the NFP and the IFP was not significantly different
(p ¼ 0.28). We suggested that it means the difference of the T-
score in the femoral neck portion between the NFP and the IFP
can be meaningful.ore and FRAX probability between femoral neck fracture patients and inter-
p Adjusted OR 95% CI p
0.031 0.744 0.529e1.048 0.090
0.953 1.076 0.807e1.433 0.619
0.282 0.927 0.682e1.260 0.630
0.002 2.297 1.354e3.897 0.002
0.012 1.055 1.012e1.100 0.012
0.012 1.070 1.012e1.132 0.018
intertrochanter fracture group.
patient.
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important for differentiating the high risk group for osteopo-
rotic fractures in the osteopenic patients. Several studies re-
ported that clinical risk factors including age, weight, personal
or family history of fractures, heritage, smoking, alcohol
consumption, and estrogen use can be significantly related to
osteoporotic fractures [14,15]. The WHO established the
FRAX® tool [4] in 2008 for estimating the 10-year probability
of hip fracture as well as the major osteoporotic fractures
(spine, forearm, or humerus) in untreated patients with
osteopenia. The tool evaluates risk based on easily obtainable
clinical risk factors, such as age, sex, BMI, history of previous
fracture, long-term glucocortcoid therapy, cigarette smoking,
and excess alcohol intake, with information on BMD. The
FRAX® tool also considers the nationality with an accumu-
lated reference from each country. The computed algorithm
(http://www.shef.ac.uk/FRAX) is used for calculations. The
National Osteoporosis Foundation (NOF) of the United States
and Osteoporosis Canada suggested that therapeutic in-
terventions are recommended if the 10-year probability of
fracture is more than 20% for major osteoporotic fractures and
more than 3% for hip fractures [5,6,16]. There were some
Asian studies (including South Korea and Japan) which
investigated the FRAX® probabilities of the population and
the percentage of the population in a high risk group for
osteoporotic fractures based on the FRAX® tool [17,18].
However, studies for patients who experienced osteoporotic
fractures are rare.
With statistical significance, the FRAX® probability of
major osteoporotic fracture in the NFP was higher than the IFP
in our study. It means that the FRAX® probability of hip
fracture is more relevant to femoral neck fractures than to
intertrochanteric fractures. Because FRAX® tool uses the
femoral neck BMD for the calculation of probability, lower T-
score of the neck portion in the femoral neck group could
affect FRAX® probability, as we assumed. High risk group for
hip fractures designated by the FRAX® tool recorded a high
sensitivity at 79.0%. This data support the therapeutic inter-
vention for patients diagnosed by their BMD as being osteo-
penic, but categorized the high risk group by the FRAX®
probability.
There are some limitations in our study. At first, we did
not measured the BMD of the proximal femur on the frac-
tured side, but on the contralateral side. We assumed that
BMD on both sides of the femur are considered similar.
Secondly, this study was done only in one institution. For this
reason, statistical power was not relatively strong, because
the number of patients was not large. A Multicenter study
with more patients should be considered for further study.
Thirdly, we changed the DEXA machines in the middle of the
study. Cross calibration of between QDR4500a and GE lunar
prodigy was not reported. But, because we focused on the
difference between T-scores of the neck portion and the
trochanteric portion in the same patients at the same exam, it
is still statistically significant even if we changed the
machine.5. Conclusions
The average of the T-scores in the neck portion was lower
than the T-scores in the trochanteric portion in both groups. In
the NFP, the average difference between the T-scores in the
neck portion and the trochanteric portion was higher than
those in the IFP. This supports the notion that localized
femoral T-scores are relevant to the fracture sites of the hip.
The high risk group designated by the FRAX® probability is a
meaningful and sensitive tool to evaluate hip fractures in
osteoporotic patients.
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